It is genuinely possible, and it is common enough to be worth checking.

In the age range where perimenopause typically occurs, roughly 1 in 10 women have a thyroid level outside the normal range, and thyroid disease risk climbs with age through midlife and beyond. A large national survey found similarly high rates of abnormal thyroid levels. Because symptoms cannot reliably separate the two conditions from each other, the standard, low-cost, low-harm way to answer this question directly is a simple thyroid blood test, and clinicians in the field describe it as a routine step that should always be part of a full midlife symptom workup.

What to know about this answer

There is no real disagreement that thyroid disease is common at this age; the disagreement is about how proactively to look for it, since population-wide screening of people without symptoms is explicitly not supported by the evidence, even though testing symptomatic women is.

What the research shows, and which source each finding rests on

In a national US biochemistry survey, hypothyroidism was found in 4.6% of the population (0.3% clinical, 4.3% subclinical) and hyperthyroidism in 1.3%; thyroid antibodies were found in over 11% of people, more common in women than men and increasing with age.

D[1]

In a large health-fair sample, elevated TSH was found in 9.5% of participants and low TSH in 2.2%; among people already taking thyroid medication, 40% had an out-of-range TSH.

D[2]

In the SWAN cohort of women aged 42-52, 9.6% had a TSH outside the normal range (6.2% above 5.0 mIU/L and 3.2% below 0.5 mIU/L).

C[3]

The hazard of developing hypothyroidism increases with age in women, and among people aged 40-49 with a TSH above 4.5 mIU/L, 67.4% test positive for thyroid antibodies, meaning an elevated TSH at this age usually reflects genuine autoimmune thyroid disease rather than a benign age-related shift.

C[4]D[5]

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

test proactively given how common and how hidden thyroid disease is

the professional society statement on thyroid disease and menopause, and clinicians who favor a low testing threshold

Because thyroid dysfunction is common at exactly this age and hides inside an overlapping symptom cloud, and because it is inexpensive to detect and treatable, the practical convergence among experts is to check a TSH once in any midlife woman whose symptoms are being attributed to perimenopause.

A[6]

population-wide screening of people without symptoms is not evidence-supported

a national task force

This body has concluded that current evidence is insufficient to assess the balance of benefits and harms of screening thyroid function in adults without symptoms, a position that has stood through a 2024 literature review; this applies to screening everyone, not to testing a woman who already has symptoms.

A[7]

What would settle it: These two positions are not actually in conflict once the distinction between population screening and symptom-based testing is made clear; both are already reflected in current guidance.

What is really going on here

  1. Population screening of people without symptoms is not evidence-supported by major task forces, but testing a symptomatic midlife woman is a different, well-supported question and is not the same as screening.
  2. An advocacy estimate that up to 60% of people with thyroid disease are unaware of it is a professional-society public-education figure, not a peer-reviewed measurement; the peer-reviewed data point to roughly 1 in 10 midlife women having an abnormal thyroid test.

Questions for your doctor

  1. Given my symptoms, is it worth checking my thyroid now?
  2. What exactly would that test involve, and what would we do with the result either way?
  3. Am I in a higher-risk group for thyroid disease for any reason?
  4. How often should this be rechecked going forward?

Questions with no answer yet

Is the widely cited estimate that up to 60% of people with thyroid disease are unaware of their condition an accurate reflection of midlife women specifically, or is it a broader population figure from a professional-society advocacy source rather than a peer-reviewed measurement?

Partly studied

What is known: The up to 60 percent unaware figure is a professional-society public-education estimate, not a peer-reviewed measurement; the peer-reviewed anchor for large-scale undetected dysfunction is national biochemistry survey data, which found roughly 1 in 10 adults with an abnormal TSH in mixed-age populations, and 9.6% specifically in midlife women in a dedicated midlife cohort.

What would test it: A peer-reviewed study specifically measuring the proportion of midlife women with undetected thyroid disease, rather than extrapolating from a broader population figure.

Does population-wide thyroid screening in symptom-free midlife women actually change health outcomes, or is testing only clearly beneficial once a woman already has symptoms or suspicion?

Partly studied

What is known: A national task force has concluded that current evidence is insufficient to assess the balance of benefits and harms of screening thyroid function in adults without symptoms, a position that has stood through a 2024 literature review; this applies specifically to screening everyone, not to testing a woman who already has symptoms, where the field converges on testing being reasonable.

What would test it: A trial measuring meaningful health outcomes, not just detection rates, from population-wide thyroid screening in symptom-free midlife women compared with symptom-based testing alone.

Sources

  1. 1.Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (NHANES III). J Clin Endocrinol Metab 2002;87(2):489-499. · Comparative or small study
  2. 2.The Colorado thyroid disease prevalence study.Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160(4):526-534. · Comparative or small study
  3. 3.Thyroid stimulating hormone (TSH) concentrations and menopausal status in women at the mid-life: SWAN.Sowers M, Luborsky J, Perdue C, et al. Thyroid stimulating hormone (TSH) concentrations and menopausal status in women at the mid-life. Clin Endocrinol (Oxf) 2003;58(3):340-347. · Observational study
  4. 4.The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey.Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43(1):55-68. · Observational study
  5. 5.Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism.Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population. J Clin Endocrinol Metab 2007;92(12):4575-4582. · Comparative or small study
  6. 6.EMAS position statement: Thyroid disease and menopause.Mintziori G, Anagnostis P, Armeni E, et al. EMAS position statement: Thyroid disease and menopause. Maturitas 2024;185:107991. · Systematic review or guideline
  7. 7.Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement.LeFevre ML, on behalf of the USPSTF. Screening for thyroid dysfunction: US Preventive Services Task Force recommendation statement. Ann Intern Med 2015;162(9):641-650. · Systematic review or guideline

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping

Related questions

Related guides